Clinical trial • Phase I • Immunology
Clinical trial in Cryopyrin associated periodic syndrome
Phase I trial for Cryopyrin associated periodic syndrome. 53 participants.
Overview
- Trial Therapeutic Area
- Immunology
- Trial Disease
- Cryopyrin associated periodic syndrome
- Trial Stage
- Phase I
Key dates
- Initial CTIS Submission Date
- 14-07-2025
- First CTIS Authorization Date
- 05-09-2025
Trial design
Phase I trial across 1 site in Netherlands.
- Target Sample Size
- 53
Recruitment
- Planned Sample Size
- 53
- Recruitment Window Months
- 10
Geography
- Total Number Of Sites
- 1
- Total Number Of Participants
- 53
Netherlands
- Earliest CTIS Part Ii Submission Date
- 04-09-2025
- Latest Decision Or Authorization Date
- 05-09-2025
- Processing Time Days
- 1
- Number Of Sites
- 1
- Number Of Participants
- 53
Sites
- Site Name
- Pharmaceutical Research Associates Group B.V.
- Department Name
- Program Management
- Contact Person Name
- Jan Leendert Brouwer
- Contact Person Email
- JanLeendert.Brouwer@iconplc.com
Sponsor
Primary sponsor
- Full Name
- Nodthera Limited
- Organisation Type
- Pharmaceutical company
- Country Of Registered Address
- United Kingdom
Contract research organisations
- Name
- Pharmaceutical Research Associates Group B.V.
- Responsibilities
- Program Management (site contact listed in trialSites)
Related trials
Other published trials that may interest you.
- BELIMUMAB for Antibody-mediated rejection (kidney transplant)|High HLA sensitization (transplant candidates)
- Belimumab for Systemic lupus erythematosus
- INEBILIZUMAB for Myasthenia gravis
- PREDNISONE for Granulomatosis with polyangiitis (Wegener's) | Microscopic polyangiitis | ANCA-associated vasculitis
- BIRCH POLLEN ALLERGOID GLUTARALDEHYDE MODIFIED for Allergic rhinitis due to birch pollen | Allergic rhinoconjunctivitis